Literature DB >> 25280917

Glioma trials and viral tribulations: can anything be concluded from non-controlled trials?

Pedro R Lowenstein1, Maria G Castro1.   

Abstract

Entities:  

Keywords:  INFECTIOUS DISEASES; NEUROIMMUNOLOGY; NEUROONCOLOGY; NEUROPATHOLOGY, VIROLOGY

Mesh：

Substances：

Year:  2014        PMID： 25280917      PMCID： PMC4677476          DOI： 10.1136/jnnp-2014-308406

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

1.  Survival in patients with glioblastoma receiving valganciclovir.

Authors:  Cecilia Söderberg-Nauclér; Afsar Rahbar; Giuseppe Stragliotto
Journal:  N Engl J Med       Date:  2013-09-05       Impact factor: 91.245

Review 2.  Cytomegalovirus and glioma: putting the cart before the horse.

Authors:  Mahua Dey; Atique U Ahmed; Maciej S Lesniak
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-06-06       Impact factor: 10.154

Review 3.  Uncertainty in the translation of preclinical experiments to clinical trials. Why do most phase III clinical trials fail?

Authors:  Pedro R Lowenstein; Maria G Castro
Journal:  Curr Gene Ther       Date:  2009-10       Impact factor: 4.391

4.  Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study.

Authors:  Giuseppe Stragliotto; Afsar Rahbar; Nina Wolmer Solberg; Anders Lilja; Chato Taher; Abiel Orrego; Birgitta Bjurman; Charlotte Tammik; Petra Skarman; Inti Peredo; Cecilia Söderberg-Nauclér
Journal:  Int J Cancer       Date:  2013-03-13       Impact factor: 7.396
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.